Stockreport

Mineralys Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]

Mineralys Therapeutics, Inc.  (MLYS) 
PDF Mineralys Therapeutics (NASDAQ:MLYS) used its fourth-quarter and full-year 2025 earnings call to highlight a key regulatory milestone for lorundrostat and to review new [Read more]